Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5576703 | The American Journal of Medicine | 2017 | 9 Pages |
Abstract
During the anticoagulation course, factor V Leiden carriers had a similar risk for venous thromboembolism recurrence and half the risk for major bleeding compared with noncarriers. This finding may contribute to decision-making regarding anticoagulation duration in selected factor V Leiden carriers with venous thromboembolism.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Inna MD, Manolis MD, Benjamin MD, Ángeles MD, PhD, Agustina MD, Philip S. MD, Olga MD, PhD, MarÃa Dolores MD, PhD, Farès MD, Manuel MD, PhD,